Corporate Action22 Sept 2026, 07:10 pm
Fredun Pharma Allots 3,61,599 Equity Shares on Warrant Conversion
AI Summary
Fredun Pharmaceuticals Ltd announced the allotment of 3,61,599 equity shares following the conversion of 1,20,533 warrants. This conversion was approved by shareholders in an EGM on October 22, 2025, with warrants initially allotted on December 29, 2025. The company's Board of Directors approved the allotment on September 16, 2026, after warrant holders paid the balance consideration. The equity shares, with a face value of Rs. 10 each, rank pari passu with existing shares. The conversion and allotment were adjusted for a recent 1:2 bonus issue.
Key Highlights
- 3,61,599 equity shares allotted upon warrant conversion.
- Conversion follows payment of balance consideration by warrant holders.
- Allotment approved by Board on September 16, 2026.
- Equity shares rank pari passu with existing shares.
- Warrant entitlement adjusted for 1:2 bonus issue.
Price Impact
More from FREDUN